Stocks Health care BSPK

OTC · Health care

Bespoke Extracts, Inc. (BSPK)

Bespoke Extracts, Inc. brought in $1.4M of revenue over the twelve months to September 30, 2025, up 31.8% from a year earlier. It posted a net loss of $730.6K. In fiscal 2024 capital spending exceeded operating cash flow by $889.8K. At September 30, 2025 it held $16.7K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 12, 2025.

Watch BSPK in 60 seconds

What Bespoke Extracts, Inc. does

Bespoke Extracts, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker BSPK.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Full financial statements: income, balance sheet and cash flow

Where BSPK ranks in Health care

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Bespoke Extracts, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. August 17, 2026
   Late quarterly report notice NT 10-Q
2. July 6, 2026
   Material agreement 8-K
3. May 18, 2026
   Late quarterly report notice NT 10-Q
4. March 31, 2026
   Late annual report notice NT 10-K
5. November 19, 2025
   Quarterly results 8-K
6. November 12, 2025
   Quarterly report 10-Q · period to September 30, 2025Revenue rose 69% to $467.9K versus the same quarter last year; diluted EPS -$0.01 versus -$0.03.
7. October 8, 2025
   Material agreement 8-K
8. August 27, 2025
   Quarterly report 10-Q · period to June 30, 2025Revenue rose 40% to $390.6K versus the same quarter last year; diluted EPS -$0.02 versus -$0.03.
9. August 14, 2025
   Late quarterly report notice NT 10-Q
10. July 7, 2025
    Quarterly results 8-K

Recent insider filings (Forms 3, 4 and 144): 10, the latest on January 8, 2026. Insider transactions on SEC

Insider trades

What the people running Bespoke Extracts, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns BSPK

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

We have not read this company's Schedule 13D and 13G filings yet.

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

1 insiders reported holding 1,000,000 shares in total, about $1.6K at the last price.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about BSPK

What does Bespoke Extracts, Inc. do?

Bespoke Extracts, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker BSPK.

Is Bespoke Extracts, Inc. profitable?

No. Over the twelve months to September 30, 2025 it reported a net loss of $730.6K on revenue of $1.4M.

How much revenue does Bespoke Extracts, Inc. make?

Over the twelve months to September 30, 2025 Bespoke Extracts, Inc. reported revenue of $1.4M. That is 31.8% more than a year earlier.

When did Bespoke Extracts, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on November 12, 2025. It covers the period to September 30, 2025. Its newest filing of any kind is the late quarterly report notice from August 17, 2026.

Similar companies

Compare BSPK with

Compare BSPK with any company

Follow BSPK

Get an email when Bespoke Extracts, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow BSPK: get an email when it files

Where the numbers come from

Financial figures are the values Bespoke Extracts, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.